← Back to Search

Exercise Testing for Chronic Respiratory Disease (VTEP Trial)

N/A

Waitlist Available

Led By Arnaud CHAMBELLAN, MD

Research Sponsored by Lille Catholic University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 40 and over

Diagnosis of chronic obstructive pulmonary disease (GOLD II - IV) or pulmonary fibrosis (>6 months)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 19 days

Awards & highlights

VTEP Trial Summary

This trial looks at two tests to measure exercise tolerance and muscle power in people with chronic respiratory disease.

Who is the study for?

This trial is for people over 40 with chronic respiratory diseases like moderate to severe COPD or pulmonary fibrosis. Participants must be able to follow verbal instructions and be covered by social security. It's not specified who can't join, but typically those with conditions affecting test performance would be excluded.Check my eligibility

What is being tested?

The study is testing the validity of two exercise tolerance tests: the six minute Stepper Test (6MST) and the 5-repetition chair lift test (5STS), against established standards in patients with chronic respiratory disease.See study design

What are the potential side effects?

Since this trial involves functional capacity tests rather than medications, side effects are minimal but may include muscle soreness or fatigue due to physical exertion during the exercises.

VTEP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 40 years old or older.

Select...

I have been diagnosed with severe lung disease for over 6 months.

VTEP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 19 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~19 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 19 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Lower limb muscle power after Five Times Sit to Stand Test (5STS,) calculated by the ratio between STS mean velocity and STS mean force

Oxygen consumption

Secondary outcome measures

Heart rate after 6MST

Leg fatigue after 6MST measured by the modified Borg scale

Lower limb muscle power after 5STS test

+4 more

VTEP Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients with a diagnosis of COPD (GOLD II- V) or pulmonary fibrosis (>6 months).Experimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Lille Catholic UniversityLead Sponsor

107 Previous Clinical Trials

28,986 Total Patients Enrolled

University of Lille Nord de FranceOTHER

12 Previous Clinical Trials

2,520 Total Patients Enrolled

Arnaud CHAMBELLAN, MDPrincipal InvestigatorHôpital Saint Philibert, GHICL

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available for prospective participants of this trial?

"As per the information available on clinicaltrials.gov, this study is no longer accepting participants; however it was initially posted on November 1st 2023 and most recently revised 6 days later. Despite its closure, there are still 917 other trials actively recruiting patients at present."

Answered by AI

What are the goals that this trial is hoping to accomplish?

"Over a 19-day period, the primary outcome measure of this trial will be oxygen consumption. Secondary outcomes include leg fatigue following 6MST - rated on a modified Borg scale ranging from 0 to 10, lower limb muscle power after 5STS test using force platform technology, and heart rate post 6MST compared to other gold standard tests."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory Disease

2023. "Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06124859.

All > Copd > Pulmonary Fibrosis